Tag: Hyloris Pharmaceuticals
AFT Pharmaceuticals spearheads progress in women’s health with Hyloris partnership
AFT Pharmaceuticals announced its partnership with Hyloris Pharmaceuticals, based in Belgium, to develop a novel treatment, HY-091, for Vulvar Lichen Sclerosus (VLS), addressing the critical need for effective solutions in an area where approved treatments are limited.
Featured Article
The economic forces driving manufacturing’s next cycle
Australia’s manufacturing sector entered 2026 with improving momentum, but renewed global disruption is again testing resilience across the industry.
